About Mitochondrial myopathy with reversible cytochrome C oxidase deficiency
Mitochondrial myopathy with reversible cytochrome C oxidase deficiency is a rare disease catalogued by Orphanet (ORPHA:254864). It is associated with the TRMU, MT-TE genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Mitochondrial myopathy with reversible cytochrome C oxidase deficiency trials.
Search ClinicalTrials.gov for "Mitochondrial myopathy with reversible cytochrome C oxidase deficiency" or filter by Orphanet code ORPHA:254864 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Mitochondrial myopathy with reversible cytochrome C oxidase deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Mitochondrial myopathy with reversible cytochrome C oxidase deficiency. Updated daily.